Clinical Trial Update: The Efficacy and Safety of Anti-inflammation Treatment (Hirudoid Introduction Followed by Yellow Light Therapy) Combined With Tofacitinib and Doxycycline in Chinese Adult Patients With Mild to Moderate Erythematous Telangiectatic Rosacea [NA]

View source ↗

Summary

A clinical trial in Chinese adults with erythematotelangiectatic rosacea is recruiting to evaluate the efficacy and safety of a Hirudoid-based anti-inflammatory…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythematotelangiectatic Rosacea
• Rosacea

Drugs mentioned

• Doxycycline (Doxycycline)
• Hirudoid (mucopolysaccharide polysulfate)
• Tofacitinib (Xeljanz) (tofacitinib)

Snippet

Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Conditions: Erythematotelangiectatic Rosacea | NA | Status: RECRUITING